Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide must be stored in a refrigerator at 2–8°C and kept away from light until you are ready to use it. That single rule covers the vast majority of situations — but knowing what to do when the pen reaches room temperature, how long you have before it degrades, and what to check before you inject is what separates a dose that works from one that may not. These are prescription-only medicines reviewed by a clinician before dispensing, and getting storage right is part of using them correctly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most of the time, the answer is straightforward. A new, unused tirzepatide KwikPen lives in the fridge, 2–8°C, away from the freezer compartment, away from the fridge door's direct cold blast, and ideally not right next to items that freeze easily. The fridge shelf is fine; tucking it behind something opaque works well for light protection.
The harder decision arises when a pen has been out of the fridge for a while, during travel, after a morning where you forgot, or over a long weekend away. There is a defined room-temperature window beyond which the medicine should not be used, but that window varies by product batch and has been updated over time. The exact time limit is stated in your pen's Patient Information Leaflet, and that is the number to rely on, not a figure from a forum or a friend's experience with a different batch. When in doubt, contact your prescriber or pharmacist before injecting.
One thing is certain: a pen that has been frozen is not safe to use. Freezing causes the formulation to degrade in ways that aren't visible. If your pen has been in the wrong section of the fridge and looks icy, or if the packaging has frost on it, treat it as compromised and seek advice.
This is where patients sometimes catch themselves off guard. Because each KwikPen delivers four weekly doses, you'll be opening the fridge door to use the same pen several times over a month. The pen goes back into the fridge after each injection, recapping the needle and returning it promptly is the habit worth building.
If you're wondering about whether an in-use pen still needs refrigeration, the answer is yes, unless you are within the confirmed room-temperature window and keeping the pen in cool, shaded conditions. A warm kitchen counter over several days is not equivalent to a stable room temperature. The SmPC is precise on this; your leaflet is the governing document.
It also pays to check the pen before each injection. Look for cloudiness, particles, discolouration, or anything that looks unusual. Tirzepatide solution should be clear to slightly yellow and free of visible particles. If something looks off, do not inject, contact your prescriber. Our guide to the injection process covers what a ready pen should look like before you use it.
Travelling with tirzepatide raises practical questions that are genuinely worth thinking through before you leave, not at the airport. The room-temperature window exists precisely for this reason (it gives flexibility for short journeys) but you need to know the specific limit for your pen and keep track of how long it has been out of cold storage.
A dedicated cool bag or insulated case with a small ice pack (with the pen wrapped so it doesn't touch ice directly) is the most reliable approach for longer trips. Direct contact with ice can freeze part of the pen, so a layer of cloth or the insulated pouch lining should sit between the pen and any cooling element.
Airports and hotel rooms present different challenges. Checked luggage holds can be very cold at altitude; keeping the pen in hand luggage is sensible. Hotel mini-fridges vary wildly in temperature, worth checking with a thermometer strip if you plan to stay several nights. For detailed travel planning, the full storage guidance page goes through each scenario step by step.
Proper disposal is the final part of the storage picture that often gets overlooked. Used needles go into a sharps container, not a household bin, not a recycling bag. Your local council or pharmacy can advise on collection points. Empty pens should be disposed of according to local waste guidance.
If you're still working out which injection site to use alongside getting storage sorted, the guidance on injection sites runs through the options. And if you're thinking about the broader practicalities of Mounjaro as a treatment (including what the cost picture looks like from a reputable, clinically supervised service) the Mounjaro cost comparison page sets out the relevant context honestly.
The NHS tirzepatide medicines page is a useful plain-English reference for storage, side effects and what to do if something seems wrong. For the most precise storage data tied to your specific pen and batch, the Mounjaro SmPC on the eMC is the authoritative document, your prescriber can point you there directly.
If you have questions about your storage situation or want a clinical view before starting treatment, speaking to our prescribers is the sensible next step. Start your free consultation and a GPhC-registered Independent Prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.